Centre takes away state powers for issuing NOC for export of drugs

Centre takes away state powers for issuing NOC for export of drugs

11-05-2024

Amid growing global scrutiny of Indian-made drugs, the central government has become the sole authority to issue manufacturing licences for new drugs for export, taking back the power from state governments.

  1. From now on the sole licensing authority will be the Central Drugs Standard Control Organization (CDSCO), India's apex drug regulatory body.

About CDSCO:

  1. The Central Drugs Standard Control Organisation (CDSCO) is the apex regulatory body for the medical device industry in India under the Drugs and Cosmetics Act. 
  2. The CDSCO works under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India.

Key Responsibilities of CDSCO:

  1. Approval of new drugs: CDSCO grants permission for the production and commercialization of new drugs in India.
  2. Conduct of clinical trials: CDSCO regulates and monitors clinical trials conducted in India to ensure the safety and rights of participants.
  3. Laying down the standards for drugs: CDSCO sets the standards for the quality, safety, and efficacy of drugs manufactured, imported, or sold in India.
  4. Control over the quality of imported drugs: CDSCO ensures that imported drugs meet the same standards as domestically produced drugs.
  5. Coordination of the activities of State Drug Control Organizations: CDSCO coordinates with State Drug Control Organizations to ensure uniform implementation of drug regulations across the country.
  6. Inspection and audits: CDSCO conducts inspections and audits of drug manufacturing facilities and laboratories to ensure compliance with regulations.
  7. Drug Controller General of India (DCGI): The DCGI is the head of the CDSCO and is responsible for its overall functioning.
  8. Headquarters: CDSCO is headquartered in New Delhi, India.

Joint Responsibility with State Regulators:

  • CDSCO, along with state regulators, is jointly responsible for granting licenses for certain specialized categories of critical drugs such as blood and blood products, I. V. Fluids, vaccines, and sera.

Must Check: Best IAS Coaching In Delhi

 

Anveshan Scheme May Be Extended

PLACES IN NEWS 24th APRIL 2025

CAN TWO ELECTORS HAVE IDENTICAL EPIC NUMBERS?